Harrow Inc (HROW)
17.69
-0.28
(-1.56%)
USD |
NASDAQ |
Jun 17, 16:00
17.72
+0.04
(+0.20%)
After-Hours: 20:00
Harrow Cash from Investing (Quarterly): -0.11M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | -0.11M |
December 31, 2023 | -0.203M |
September 30, 2023 | -20.13M |
June 30, 2023 | -1.249M |
March 31, 2023 | -130.97M |
December 31, 2022 | -0.005M |
September 30, 2022 | -1.069M |
June 30, 2022 | -0.259M |
March 31, 2022 | -0.41M |
December 31, 2021 | -14.20M |
September 30, 2021 | -12.93M |
June 30, 2021 | 8.669M |
March 31, 2021 | -0.224M |
December 31, 2020 | -0.09M |
September 30, 2020 | -0.281M |
June 30, 2020 | -0.337M |
March 31, 2020 | -0.273M |
December 31, 2019 | -0.969M |
September 30, 2019 | -0.079M |
June 30, 2019 | -0.461M |
March 31, 2019 | -0.324M |
December 31, 2018 | -0.852M |
September 30, 2018 | -0.647M |
June 30, 2018 | -0.436M |
March 31, 2018 | -0.264M |
Date | Value |
---|---|
December 31, 2017 | -0.249M |
September 30, 2017 | -0.197M |
June 30, 2017 | -0.299M |
March 31, 2017 | -0.216M |
December 31, 2016 | -0.164M |
September 30, 2016 | -1.145M |
June 30, 2016 | -3.557M |
March 31, 2016 | -2.423M |
December 31, 2015 | -0.871M |
September 30, 2015 | -1.046M |
June 30, 2015 | -0.18M |
March 31, 2015 | -3.033M |
December 31, 2014 | -0.082M |
September 30, 2014 | -0.077M |
June 30, 2014 | -0.70M |
March 31, 2014 | -0.051M |
December 31, 2013 | -0.0095M |
September 30, 2013 | -0.0053M |
June 30, 2013 | -0.0037M |
March 31, 2013 | -0.0514M |
December 31, 2012 | -0.0002M |
September 30, 2012 | 0.00 |
June 30, 2012 | -0.0007M |
March 31, 2012 | -0.0146M |
December 31, 2011 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-130.97M
Minimum
Mar 2023
8.669M
Maximum
Jun 2021
-8.779M
Average
-0.309M
Median
Cash from Investing (Quarterly) Benchmarks
Durect Corp | -0.887M |
Aquestive Therapeutics Inc | -0.029M |
Cyclacel Pharmaceuticals Inc | 0.00 |
Stereotaxis Inc | 0.00 |
Cara Therapeutics Inc | 25.95M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -4.628M |
Cash from Financing (Quarterly) | -0.809M |
Free Cash Flow | -14.27M |
Free Cash Flow Per Share (Quarterly) | -0.1336 |
Free Cash Flow to Equity (Quarterly) | -5.714M |
Free Cash Flow to Firm (Quarterly) | 0.677M |
Free Cash Flow Yield | -2.38% |